Aurinia Pharmaceuticals is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs
Aurinia Pharmaceuticals is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. They introduced LUPKYNIS, the first FDA-approved oral therapy for lupus nephritis, and are developing aritinercept for autoimmune diseases.